Prior Expectations
FY25
From H2 reversal collapses FY25 NPAT to NZ$0.3m from NZ$37.2m
No quantitative targets, forward-work metric, or NTA disclosure were extracted, so there is no management benchmark to test the result against. Seasonality is not meaningful for an investment vehicle — the HY25-to-FY25 shape (first-half share of 192% of full-year revenue and 2,439% of full-year NPAT) is a mark-to-market reversal, not a seasonal pattern. The release therefore supports a read that H2 market/portfolio moves wiped out interim gains, but does not support any view on FY26 portfolio direction.